Skip to main content

FATE

Fate Therapeutics Inc
$2.42 +0.32 (+15.24%)
2 Up Days

Price & Indicators

50d MA 200d MA Earnings Filing Insider Congress Investor day
Equibles Rating blended score
Overall
Neutral
Technical · trend & momentum Buy
+ Price vs 200-day avg · +75% above
Sentiment · smart money Bearish
Insider flow · Net -$102.6K over 90 days · 100% sells
Fundamentals Fair
+ EPS growth · +30% Y/Y

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Key facts
Market Cap
$282.07M
Shares
116,559,186
CIK
1434316
CUSIP
31189P102
13F Activity (30d)
3 filings 3 filers
Investor Relations
Investor relations

Daily candlestick prices with configurable technical indicators (moving averages, Bollinger Bands, RSI, MACD) and event bullets for 10-K, 10-Q, Form 4 and earnings dates. Price data syncs automatically from Yahoo Finance.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 3
50 / 200-day cross
no cross Neutral
Price vs 200-day avg
+75% above Bullish
Price vs 50-day avg
+23% above Bullish
RSI (14)
60 · neutral Neutral
MACD trend
positive Bullish
52-week position
77% · mid-range Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow Accumulating
+7% holders QoQ · +26 funds added
Insider flow Distributing
Net -$102.6K over 90 days · 100% sells
Short interest Rising
9.28% of float · ▲ +1.2% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
156 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1 Now $2 · 77% 52-wk high $3
vs 200-day avg +75% vs 50-day avg +23%

Illustrative technical + ownership context — a signal mix, not investment advice.

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
156
% held
60.1%
Net QoQ
-2.2M sh
Top holder
Redmile Group, LLC
Held Float
View
Held by Funds
Fund positions
122
View
Short & Settlement
Short Interest Rising
Shares short
10.8M
Days to cover
3.0d
Change
+124.6K sh
View
Short Volume
Short vol %
35%
As of
Jun 30, 2026
Short Total
View
Fails to Deliver
FTD shares
7.9K
Value
$15.7K
As of
Jun 12, 2026
View
Off-Exchange
Off-exchange %
47.0%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$102.6K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Jan 31, 2023
View
Financials
Financials
Revenue (FY)
$6.6M
Net income (FY)
$-136.3M
EPS diluted
$-1.15
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 15, 2026
This year
7
View
Proposed Sales
Value
$54.5K
Shares
28.9K
Filed
May 20, 2026
View
Exempt Offerings
Offering
$50.0M
Filed
Jul 6, 2020
View
Earnings & Events
Earnings Calls
Last call
May 13, 2026
View
Investor Relations
Latest news
Fate Therapeutics Appoints Laura…
Published
Jun 15, 2026
View

Performance

5D 20D 120D MTD YTD
FATE +14.4% -14.8% +139.6% -14.8% +146.9%
SPY -0.5% -2.1% +7.8% -2.1% +8.7%
vs SPY +14.9% -12.7% +131.9% -12.7% +138.3%
Close
$2.42
Open
$2.17
Day Range
$2.08 — $2.48
52W High
$2.88
52W Low
$0.91
Avg Vol (30d)
4.2M
Short Interest
10.8M · 3.0d
Short Vol % (latest)
35%
Last Earnings
2026-05-13
Latest Filing
Data Range
2020-01-02 — 2026-06-29